Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yudi Ma

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Optics Express|July 19, 2020
Precise pulse shaping for quantum control of strong optical transitionsYudi Ma, Xing Huang, Xiaoqing Wang, et al.
Physical Review Letters|December 4, 2020
Geometric Control of Collective Spontaneous EmissionYizun He, Lingjing Ji, Yuzhuo Wang, et al.
Microbial Biotechnology|November 6, 2022
The host niches of soybean rather than genetic modification or glyphosate application drive the assembly of root-associated microbial communitiesMinkai Yang, Fuhe Luo, Yuchen Song, et al.
European Journal of Medicinal Chemistry|February 2, 2023
PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolismHongyan Lin, Hongwei Han, Minkai Yang, et al.
Life Sciences|October 16, 2022
Novel shikonin derivatives suppress cell proliferation, migration and induce apoptosis in human triple-negative breast cancer cells via regulating PDK1/PDHC axisQingqing Chen, Hongwei Han, Faxiang Lin, et al.
Bioorganic Chemistry|November 26, 2024
Trametinib and M17, a novel small molecule inhibitor of AKT, display a synergistic antitumor effect in triple negative breast cancer cells through the AKT/mTOR and MEK/ERK pathwaysHongwei Han, Minkai Yang, Zhongling Wen, et al.
Journal of Applied Microbiology|July 8, 2022
Anti-microbial efficacy, mechanisms and druggability evaluation of the natural flavonoidsHongyan Lin, Jiabao Hu, Feng Mei, et al.
Chinese Journal of Natural Medicines|May 18, 2025
Comprehensive analysis of the antibacterial activity of 5,8-dihydroxy-1,4-naphthoquinone derivatives against methicillin-resistant Staphylococcus aureusQingqing Chen, Yuhang Ding, Zhongyi Li, et al.
Bioorganic Chemistry|July 3, 2023
Design, synthesis and biological evaluation of novel modified dual-target shikonin derivatives for colorectal cancer treatmentYudi Ma, Xiaohui Lai, Zhongling Wen, et al.
Chemical Biology & Drug Design|May 21, 2025
Novel Phenoxyacetic Acid (4-Aminophenoacetic Acid) Shikonin Ester Kills KRAS Mutant Colon Cancer Cells via Targeting the Akt Allosteric SiteYudi Ma, Yuqian Sun, Qingqing Tu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Optics Express|July 19, 2020
Precise pulse shaping for quantum control of strong optical transitionsYudi Ma, Xing Huang, Xiaoqing Wang, et al.
Physical Review Letters|December 4, 2020
Geometric Control of Collective Spontaneous EmissionYizun He, Lingjing Ji, Yuzhuo Wang, et al.
Microbial Biotechnology|November 6, 2022
The host niches of soybean rather than genetic modification or glyphosate application drive the assembly of root-associated microbial communitiesMinkai Yang, Fuhe Luo, Yuchen Song, et al.
European Journal of Medicinal Chemistry|February 2, 2023
PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolismHongyan Lin, Hongwei Han, Minkai Yang, et al.
Life Sciences|October 16, 2022
Novel shikonin derivatives suppress cell proliferation, migration and induce apoptosis in human triple-negative breast cancer cells via regulating PDK1/PDHC axisQingqing Chen, Hongwei Han, Faxiang Lin, et al.
Bioorganic Chemistry|November 26, 2024
Trametinib and M17, a novel small molecule inhibitor of AKT, display a synergistic antitumor effect in triple negative breast cancer cells through the AKT/mTOR and MEK/ERK pathwaysHongwei Han, Minkai Yang, Zhongling Wen, et al.
Journal of Applied Microbiology|July 8, 2022
Anti-microbial efficacy, mechanisms and druggability evaluation of the natural flavonoidsHongyan Lin, Jiabao Hu, Feng Mei, et al.
Chinese Journal of Natural Medicines|May 18, 2025
Comprehensive analysis of the antibacterial activity of 5,8-dihydroxy-1,4-naphthoquinone derivatives against methicillin-resistant Staphylococcus aureusQingqing Chen, Yuhang Ding, Zhongyi Li, et al.
Bioorganic Chemistry|July 3, 2023
Design, synthesis and biological evaluation of novel modified dual-target shikonin derivatives for colorectal cancer treatmentYudi Ma, Xiaohui Lai, Zhongling Wen, et al.
Chemical Biology & Drug Design|May 21, 2025
Novel Phenoxyacetic Acid (4-Aminophenoacetic Acid) Shikonin Ester Kills KRAS Mutant Colon Cancer Cells via Targeting the Akt Allosteric SiteYudi Ma, Yuqian Sun, Qingqing Tu, et al.
Pageof 3